ACETIROMATE

Possibly Marketed Outside US

Details

Stereochemistry	ACHIRAL
Molecular Formula	C15H9I3O5
Molecular Weight	649.9424
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=O)OC1=CC=C(OC2=C(I)C=C(C=C2I)C(O)=O)C=C1I

InChI

InChIKey=AXVCIZJRCOHMQX-UHFFFAOYSA-N

InChI=1S/C15H9I3O5/c1-7(19)22-13-3-2-9(6-10(13)16)23-14-11(17)4-8(15(20)21)5-12(14)18/h2-6H,1H3,(H,20,21)

HIDE SMILES / InChI

Molecular Formula	C15H9I3O5
Molecular Weight	649.9424
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4142437

Acetiromate was studied to treat patients with hyperlipidemia.

Approval Year

PubMed

Title	Date	PubMed
Long-term administration of 3,5-diodo-4(3'-iodo4'-acetoxyphenoxy) benzoic acid (acetiromate) in hyperlipidemic patients.	1974-08	4142437
[Therapeutic of acetiromate on hyperlipidemia--comparison with clofibrate using a double-blind method].	1974-07-10	4612204

Sample Use Guides

In Vivo Use Guide

A daily dose of 20-50 mg of 3, 5-diiodo-4 (3'-iodo-4'-acetoxyphenoxy) benzoic acid (acetiromate) was given to four hyperlipidemic patients for a long period ranging from 2 years and 8 months to 5 years and 6 months.

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:33:20 GMT 2025` Edited by `admin` on `Mon Mar 31 18:33:20 GMT 2025`
Record UNII	8Q5153W1NW
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ACETIROMATE [MART.]

Preferred Name

English

ACETIROMATE

Official Name

English

acetiromate [INN]

Common Name

English

4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOBENZOIC ACID ACETATE

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29703